Deniaud-Alexandre E, Touboul E, Lerouge D, Grahek D, Foulquier J N, Petegnief Y, Grès B, El Balaa H, Keraudy K, Kerrou K, Montravers F, Milleron B, Lebeau B, Talbot J-N
Service d'oncologie-radiothérapie, hôpital Tenon, AP-HP, 4, rue de la Chine, 75970 Paris cedex 20, France.
Cancer Radiother. 2005 Sep;9(5):304-15. doi: 10.1016/j.canrad.2005.07.002. Epub 2005 Aug 8.
To report a retrospective study concerning the impact of fused 18F-fluorodeoxy-D-glucose (FDG)-hybrid positron emission tomography (PET) and computed tomography (CT) images on three-dimensional conformal radiation therapy (3D-CRT) planning for patients with non-small-cell lung cancer (NSCLC).
One hundred and one patients consecutively treated for stages I-III NSCLC were studied. Each patient underwent CT and FDG-hybrid PET for simulation treatment in the same radiation treatment position. Images were coregistered using five fiducial markers. Target volume delineation was initially performed on the CT images and the corresponding FDG-PET data were subsequently used as an overlay to the CT data to define target volume.
FDG-PET identified previously undetected distant metastatic disease in 8 patients making them ineligible for curative CRT (one patient presented some positive uptakes corresponding to concomitant pulmonary tuberculosis). Another patient was ineligible for curative treatment because fused CT/PET images demonstrated excessively extensive intrathoracic disease. The gross tumor volume (GTV) was decreased by CT/PET image fusion in 21 patients (23%) and was increased in 24 patients (26%). The GTV reduction was > or = 25% in 7 patients because CT/PET image fusion reduced pulmonary GTV in 6 patients (3 patients with atelectasis) and mediastinal nodal GTV in 1 patient. The GTV increase was > or = 25% in 14 patients due to an increase of the pulmonary GTV in 11 patients (4 patients with atelectasis) and detection of occult mediastinal lymph node involvement in 3 patients. Among 81 patients receiving a total dose > or = 60 Gy at ICRU point, after CT/PET image fusion, the percentage of total lung volume receiving more than 20 Gy (VL20) increased in 15 cases and decreased in 22 cases. The percentage of total heart volume receiving more than 36 Gy increased in 8 patients and decreased in 14 patients. The spinal cord volume receiving at least 45 Gy (2 patients) decreased. After multivariate analysis, one single independent factor made significant effect of FDG/PET on the modification of the size of the GTV: tumor with atelectasis (P = 0.0001). Conclusion. - Our study confirms that integrated hybrid PET/CT in the treatment position and coregistered images have an impact on treatment planning and management of patients with NSCLC. FDG images using dedicated PET scanners with modern image fusion techniques and respiration-gated acquisition protocols could improve CT/PET image coregistration. However, prospective studies with histological correlation are necessary and the impact on treatment outcome remains to be demonstrated.
报告一项关于融合18F-氟脱氧-D-葡萄糖(FDG)的正电子发射断层显像(PET)与计算机断层扫描(CT)图像对非小细胞肺癌(NSCLC)患者三维适形放射治疗(3D-CRT)计划影响的回顾性研究。
对连续接受I - III期NSCLC治疗的101例患者进行研究。每位患者在相同放疗体位下接受CT和FDG融合PET模拟治疗。使用五个基准标记进行图像配准。最初在CT图像上进行靶区勾画,随后将相应的FDG-PET数据作为CT数据的叠加层以定义靶区。
FDG-PET在8例患者中发现了先前未检测到的远处转移病灶,使其不符合根治性CRT标准(1例患者出现一些对应于合并肺结核的阳性摄取)。另1例患者因融合的CT/PET图像显示胸腔内疾病范围过大而不符合根治性治疗标准。21例患者(23%)的大体肿瘤体积(GTV)通过CT/PET图像融合减小,24例患者(26%)增大。7例患者的GTV减小≥25%,因为CT/PET图像融合使6例患者(3例肺不张患者)的肺GTV和1例患者的纵隔淋巴结GTV减小。14例患者的GTV增大≥25%,原因是11例患者(4例肺不张患者)的肺GTV增大以及3例患者检测到隐匿性纵隔淋巴结受累。在81例在ICRU点接受总剂量≥60 Gy的患者中,CT/PET图像融合后,接受超过20 Gy(VL20)的全肺体积百分比在15例患者中增加,在22例患者中减少。接受超过36 Gy的全心体积百分比在8例患者中增加,在14例患者中减少。接受至少45 Gy的脊髓体积(2例患者)减小。多因素分析后,一个单一独立因素使FDG/PET对GTV大小的改变有显著影响:合并肺不张的肿瘤(P = 0.0001)。结论。 - 我们的研究证实,治疗体位下的融合PET/CT及配准图像对NSCLC患者的治疗计划和管理有影响。使用具有现代图像融合技术和呼吸门控采集协议的专用PET扫描仪的FDG图像可改善CT/PET图像配准。然而,需要进行有组织学相关性的前瞻性研究,且对治疗结果的影响仍有待证实。